Skip to main content

Table 12 Factors that would encourage pharmacists to report an ADRs and implement PV system (n = 342)

From: A national survey of knowledge, attitude, practice, and barriers towards pharmacovigilance and adverse drug reaction reporting among hospital pharmacy practitioners in the United Arab Emirates

Statement

Level of agreement, n (%)

Median (IQR) scores

 

Strongly Disagree (1)

Disagree (2)

Neutral (3)

Agree (4)

Strongly Agree (5)

 

1. There should be incentives for the pharmacist who perform the reporting

9 (2.6)

34 (9.9)

62 (18.1)

143 (41.8)

94 (27.5)

4 (3–5)

2. Availability of ADR reporting center in each hospital will enhance PV activity

1 (0.3)

5 (1.5)

20 (5.9)

167 (48.8)

149 (43.6)

4 (4–5)

3. Direct ADR reporting by patients to national PV center

16 (4.7)

52 (15.2)

92 (26.9)

122 (35.7)

60 (17.5)

4 (3–4)

4. Proper training regarding the procedure of reporting ADRs will encourage reporting by pharmacists

0

4 (1.2)

12 (3.5)

176 (51.5)

150 (43.9)

4 (4–5)

5. Legal protection should be provided to the pharmacists by their workplace or by the relevant authority if they have dispensed the medication causing ADR

5 (1.5)

9 (2.6)

29 (8.5)

153 (44.7)

146 (42.7)

4 (4–5)

6. Continuous education and workshops for pharmacists

3 (0.9)

2 (0.6)

13 (3.8)

117 (34.2)

207 (60.5)

5 (4–5)

7. Encourage all health professionals to report

2 (0.6)

2 (0.6)

12 (3.5)

109 (31.9)

217 (63.5)

5 (4–5)

8. Ease of access to ADR forms

2 (0.6)

9 (2.6)

13 (3.8)

114 (33.3)

204 (59.7)

5 (4–5)

9. Using information technology in facilitating ADR reporting in the country

2 (0.6)

4 (1.2)

9 (2.6)

130 (38)

197 (57.6)

5 (4–5)

10. PV should be taught in the pharmacy curriculum

6 (1.8)

3 (0.9)

24 (7)

121 (35.4)

188 (55)

5 (4–5)

11. Difficult to decide whether or not an ADR has occurred

16 (4.7)

46 (13.5)

77 (22.5)

101 (29.5)

102 (29.8)

4 (3–5)